- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x P8V: 2-[5-(cyclopropylmethyl)-4-[(3-fluoro-4-sulfamoylphenyl)methyl]-3-{3-[(5-methylthiophen-2-yl)ethynyl]phenyl}-1H-pyrazol-1-yl]-1,3-thiazole-4-carboxylic acid(Non-covalent)
P8V.2: 21 residues within 4Å:- Chain A: R.106, L.109, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323
- Ligands: NAI.1, EDO.4
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:R.106, A:L.109, A:V.110, A:N.138, A:P.139, A:P.139, A:I.142, A:A.238, A:Y.239
- Hydrogen bonds: A:N.138, A:D.141, A:D.141, A:D.141, A:I.142, A:T.248
- Salt bridges: A:R.169, A:H.193
P8V.9: 21 residues within 4Å:- Chain B: R.106, L.109, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323
- Ligands: NAI.8, EDO.11
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:R.106, B:L.109, B:V.110, B:N.138, B:P.139, B:P.139, B:I.142, B:A.238, B:Y.239
- Hydrogen bonds: B:N.138, B:D.141, B:D.141, B:D.141, B:I.142, B:T.248
- Salt bridges: B:R.169, B:H.193
P8V.16: 20 residues within 4Å:- Chain C: R.106, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323, I.326
- Ligands: NAI.15
15 PLIP interactions:15 interactions with chain C- Hydrophobic interactions: C:V.110, C:N.138, C:P.139, C:P.139, C:A.238, C:Y.239
- Hydrogen bonds: C:N.138, C:D.141, C:D.141, C:I.142, C:E.192, C:T.248, C:T.248
- Salt bridges: C:R.169, C:H.193
P8V.19: 20 residues within 4Å:- Chain D: R.106, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323, I.326
- Ligands: NAI.18
15 PLIP interactions:15 interactions with chain D- Hydrophobic interactions: D:V.110, D:N.138, D:P.139, D:P.139, D:A.238, D:Y.239
- Hydrogen bonds: D:N.138, D:D.141, D:D.141, D:I.142, D:E.192, D:T.248, D:T.248
- Salt bridges: D:R.169, D:H.193
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 3 residues within 4Å:- Chain A: H.231, K.232, E.236
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.231, A:E.236
EDO.4: 4 residues within 4Å:- Chain A: R.106, Y.239, I.242
- Ligands: P8V.2
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.106
EDO.5: 2 residues within 4Å:- Chain A: P.122, N.123
1 PLIP interactions:1 interactions with chain A- Water bridges: A:N.123
EDO.6: 3 residues within 4Å:- Chain A: E.261, R.269
- Chain D: L.183
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:D.258, A:R.269, A:R.269
- Water bridges: A:K.42, A:K.42, A:K.42, A:D.258, C:F.71
EDO.7: 6 residues within 4Å:- Chain A: N.11, L.13, E.15
- Chain B: R.268, S.301, D.302
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.268, B:R.268, B:S.301, A:N.11, A:E.15
EDO.10: 3 residues within 4Å:- Chain B: H.231, K.232, E.236
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.231, B:E.236
EDO.11: 4 residues within 4Å:- Chain B: R.106, Y.239, I.242
- Ligands: P8V.9
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.106
EDO.12: 2 residues within 4Å:- Chain B: P.122, N.123
1 PLIP interactions:1 interactions with chain B- Water bridges: B:N.123
EDO.13: 3 residues within 4Å:- Chain B: E.261, R.269
- Chain C: L.183
8 PLIP interactions:1 interactions with chain D, 7 interactions with chain B- Water bridges: D:F.71, B:K.42, B:K.42, B:K.42, B:D.258
- Hydrogen bonds: B:D.258, B:R.269, B:R.269
EDO.14: 6 residues within 4Å:- Chain A: R.268, S.301, D.302
- Chain B: N.11, L.13, E.15
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:N.11, B:E.15, A:R.268, A:R.268, A:S.301
EDO.17: 7 residues within 4Å:- Chain B: S.202, G.208
- Chain C: S.202, G.203, N.205, G.208, S.210
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:S.202, C:G.208
- Water bridges: C:S.210, C:L.211, C:T.213
EDO.20: 7 residues within 4Å:- Chain A: S.202, G.208
- Chain D: S.202, G.203, N.205, G.208, S.210
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:S.202, D:G.208
- Water bridges: D:S.210, D:L.211, D:T.213
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rai, G. et al., Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties. J.Med.Chem. (2020)
- Release Date
- 2020-09-23
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
DC
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x P8V: 2-[5-(cyclopropylmethyl)-4-[(3-fluoro-4-sulfamoylphenyl)methyl]-3-{3-[(5-methylthiophen-2-yl)ethynyl]phenyl}-1H-pyrazol-1-yl]-1,3-thiazole-4-carboxylic acid(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rai, G. et al., Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties. J.Med.Chem. (2020)
- Release Date
- 2020-09-23
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
DC
BD
B